MaxCyte
United StatesEntry
2021
Hold
5yr
Status
Active
Who owns MaxCyte?
MaxCyte is an American Biotech company, currently owned by Vitruvian Partners since 2021 and Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Vitruvian PartnersVitruvian Investment Partnership IV · 2020 · Growth
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Crossover Fund I · 2018 · VC
Vitruvian PartnersActive
2021 · present(5yr) · Vitruvian Investment Partnership IV · 2020 · Growth
More from Vitruvian Investment Partnership IV
Other portfolio companies in the same fund.
UK
SpainMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns MaxCyte?
MaxCyte is currently owned by Vitruvian Partners and Sofinnova Partners, through Vitruvian Investment Partnership IV, since 2021.
When did Vitruvian Partners and 1 other acquire MaxCyte?
Vitruvian Partners and 1 other acquired MaxCyte in 2021.
Who has owned MaxCyte over time?
MaxCyte has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Crossover Fund I · since 2019; Vitruvian Partners · via Vitruvian Investment Partnership IV · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue